BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38728507)

  • 21. Orbital lymphoma: diagnostic approach and treatment outcome.
    Eckardt AM; Lemound J; Rana M; Gellrich NC
    World J Surg Oncol; 2013 Mar; 11():73. PubMed ID: 23506357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous lymphomas: single center experience of dermatology and hematology clinics.
    Payzin B; Ogretmen Z; Cidem Yildirim A; Ozturk Durur S; Sentekin S
    J BUON; 2014; 19(1):171-7. PubMed ID: 24659660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Colonic primary lymphoma].
    Villanueva-Sáenz E; Alvarez-Tostado Fernández JF; Martínez Hernández-Magro P; Valdés-Ovalle M; Peña Ruiz-Esparza JP
    Rev Gastroenterol Mex; 2002; 67(1):28-33. PubMed ID: 12066428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
    Abramson JS; Feldman T; Kroll-Desrosiers AR; Muffly LS; Winer E; Flowers CR; Lansigan F; Nabhan C; Nastoupil LJ; Nath R; Goy A; Castillo JJ; Jagadeesh D; Woda B; Rosen ST; Smith SM; Evens AM
    Ann Oncol; 2014 Nov; 25(11):2211-2217. PubMed ID: 25193992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 10
    Owattanapanich W; Ruchutrakool T; Pongpruttipan T; Maneerattanaporn M
    Hematology; 2021 Dec; 26(1):249-255. PubMed ID: 33618613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
    Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
    [No Abstract]   [Full Text] [Related]  

  • 27. Colon lymphomas: an analysis of our experience over the last 23 years.
    Martín Domínguez V; Mendoza J; Díaz Menéndez A; Adrados M; Moreno Monteagudo JA; Santander C
    Rev Esp Enferm Dig; 2018 Dec; 110(12):762-767. PubMed ID: 30168340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary lymphoma of the large intestine.
    Henry CA; Berry RE
    Am Surg; 1988 May; 54(5):262-6. PubMed ID: 3364860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in primary gastric lymphoma.
    Medina-Franco H; Germes SS; Maldonado CL
    Ann Surg Oncol; 2007 Aug; 14(8):2239-45. PubMed ID: 17546474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
    Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG).
    Cortelazzo S; Rossi A; Roggero F; Oldani E; Zucca E; Tondini C; Ambrosetti A; Pasini F; Pinotti G; Bertini M; Vitolo U; Busetto M; Gianni L; Cavalli F; Barbui T
    Ann Oncol; 1999 Dec; 10(12):1433-40. PubMed ID: 10643533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group.
    Ryan G; Martinelli G; Kuper-Hommel M; Tsang R; Pruneri G; Yuen K; Roos D; Lennard A; Devizzi L; Crabb S; Hossfeld D; Pratt G; Dell'Olio M; Choo SP; Bociek RG; Radford J; Lade S; Gianni AM; Zucca E; Cavalli F; Seymour JF;
    Ann Oncol; 2008 Feb; 19(2):233-41. PubMed ID: 17932394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
    Skacel M; Ross CW; Hsi ED
    Histopathology; 2000 Jul; 37(1):10-8. PubMed ID: 10931213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of surgery and rituximab in primary gastric diffuse large B-cell lymphoma].
    Huang HW; Jiang YB; Fu TW; Xu T; Chen XC; Jin ZM; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jul; 37(7):602-6. PubMed ID: 27535862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.
    Maeshima AM; Taniguchi H; Toyoda K; Yamauchi N; Makita S; Fukuhara S; Munakata W; Maruyama D; Kobayashi Y; Tobinai K
    Br J Haematol; 2016 Sep; 174(6):923-31. PubMed ID: 27460179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
    Xiao M; Lin J; Xiao T; Lin Y; Ye Y
    Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Gastrointestinal Lymphoma: A Retrospective Multicenter Clinical Study of 415 Cases in Chinese Province of Guangdong and a Systematic Review Containing 5075 Chinese Patients.
    Chen Y; Chen Y; Chen S; Wu L; Xu L; Lian G; Yang K; Li Y; Zeng L; Huang K
    Medicine (Baltimore); 2015 Nov; 94(47):e2119. PubMed ID: 26632732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era.
    Lim RMH; Chan NPX; Khoo LP; Cheng CL; Tan L; Poon EYL; Somasundaram N; Farid M; Tang TPL; Tao M; Lim ST; Chan JY
    Sci Rep; 2020 Mar; 10(1):4373. PubMed ID: 32152442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
    Ayers EC; Li S; Medeiros LJ; Bond DA; Maddocks KJ; Torka P; Mier Hicks A; Curry M; Wagner-Johnston ND; Karmali R; Behdad A; Fakhri B; Kahl BS; Churnetski MC; Cohen JB; Reddy NM; Modi D; Ramchandren R; Howlett C; Leslie LA; Cytryn S; Diefenbach CS; Faramand R; Chavez JC; Olszewski AJ; Liu Y; Barta SK; Mukhija D; Hill BT; Ma H; Amengual JE; Nathan S; Assouline SE; Orellana-Noia VM; Portell CA; Chandar A; David KA; Giri A; Hess BT; Landsburg DJ
    Cancer; 2020 Jan; 126(2):293-303. PubMed ID: 31568564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.